Emily Doyle
No más puestos en curso
Perfil
Emily Doyle served as Vice President-Global Human Resources at Globus Medical, Inc. from 2018 to 2019.
Prior to that, she was Head-Human Resources at AstraZeneca AB from 2015 to 2017.
She also held the position of Senior Vice President-Global Human Resources at Strongbridge Biopharma Plc.
Ms. Doyle received an undergraduate degree from Metropolitan State University of Denver.
Antiguos cargos conocidos de Emily Doyle.
Empresas | Cargo | Fin |
---|---|---|
GLOBUS MEDICAL, INC. | Oficial de Recursos Humanos | 01/03/2019 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Oficial de Recursos Humanos | 01/01/2017 |
STRONGBRIDGE BIOPHARMA | Oficial de Recursos Humanos | - |
Formación de Emily Doyle.
Metropolitan State University of Denver | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
GLOBUS MEDICAL, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Strongbridge Biopharma Plc
Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Bolsa de valores
- Insiders
- Emily Doyle